Sudha Rao
Professor Sudha Rao has extensive experience in transcriptional biology and genomic technologies that spans both pharmaceutical and academic settings. The primary focus of Professor Rao’s research group has been to unravel complex epigenetic-signatures in the immune system, as well as to understand the deregulatory mechanisms operating in cancer settings. She obtained her BSC (Hons.) degree at Keele University, UK and PhD from the University of London, Kings College. At this time, she joined a team of scientists at Rhone Poulenc/Sanofi Pharma, both in UK and France. During this period, she was part of one of the first groups world-wide to establish the clinical genomics platform for therapeutics in the UK. Professor Rao currents heads the Gene Regulation & Translational Medicine laboratory at QIMRB and recently the recipient of the MTP REDI Fellowship & the inaugural Daniela Dwyer Fellowship. Professor Rao has developed close partnerships with global technology companies and established novel liquid biopsy clinical platforms, first of its kind in Asia, for non-invasive tracking of blood samples from cancer patients. She has attracted highly competitive NHMRC, ARC and commercial funding to advance her cancer work. Professor Rao’s work has yielded national and international patents for both novel diagnostics and therapeutics in the emerging arena of immune-oncology and this work has great potential for cancer patients.
Abstracts this author is presenting: